CALDWELL, TIMOTHY MALCOLM,PATT, WILLIAM C.,SAMARAKOON, THIWANKA,VOGETI, LAKSHMINARAYANA,YATES, KAREN M.,FLYNN, DANIEL L.,KAUFMAN, MICHAEL D.
申请号:
CA2903288
公开号:
CA2903288A1
申请日:
2014.03.14
申请国别(地区):
CA
年份:
2014
代理人:
摘要:
Described are compounds of Formula I, which find utility in the treatment of cancer, autoimmune diseases and metabolic bone disorders through inhibition of c-FMS (CSF-IR), c-KIT, and/or PDGFR kinases. These compounds also find utility in the treatment of other mammalian diseases mediated by c- FMS, c-KIT, or PDGFR kinases.